Skip to main content
SpringerLink
Log in

Special Disease Management Considerations

  • Chapter
  • First Online:
Intracerebral Hemorrhage Therapeutics

  • 526 Accesses

Abstract

In this chapter, we present clinical scenarios of patients with spontaneous intracerebral hemorrhage, intraventricular hemorrhage, and hemorrhages secondary to underlying brain arteriovenous malformation and dural arteriovenous fistulas. Based on current available evidence, we also discuss management for each of the above conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD, STICH Investigators. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl. 2006;96:65–8.

    Article  CAS  PubMed  Google Scholar 

  2. Witsch J, Bruce E, Meyers E, Velazquez A, Schmidt JM, Suwatcharangkoon S, et al. Intraventricular hemorrhage expansion in patients with spontaneous intracerebral hemorrhage. Neurology. 2015;84(10):989–94.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Passero S, Ulivelli M, Reale F. Primary intraventricular haemorrhage in adults. Acta Neurol Scand. 2002;105:115–9.

    Article  CAS  PubMed  Google Scholar 

  4. Zhu XL, Chan MS, Poon WS. Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke. 1997;28:1406–9.

    Article  CAS  PubMed  Google Scholar 

  5. Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–60.

    Article  PubMed  Google Scholar 

  6. Wang YC, Lin CW, Shen CC, Lai SC, Kuo JS. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship. J Neurol Sci. 2002;202(1–2):35–41.

    Article  CAS  PubMed  Google Scholar 

  7. Ávila C, Lozano C, De La Cueva VA, Moliner J, López M, San Miguel F, et al. Intraventricular hemorrhage treated with intraventricular fibrinolysis: a 10-year experience. Med Intensiva. 2013;37:61–6.

    Article  Google Scholar 

  8. Dunatov S, Antoncic I, Bralic M, Jurjevic A. Intraventricular thrombolysis with rt-PA in patients with intraventricular hemorrhage. Acta Neurol Scand. 2011;124:343–8.

    Article  CAS  PubMed  Google Scholar 

  9. Fountas KN, Kapsalaki EZ, Parish DC, Smith B, Smisson HF, Johnston KW, et al. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage. South Med J. 2005;98:767–73.

    Article  CAS  PubMed  Google Scholar 

  10. Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA, et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011;42:3009–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lapointe M, Haines S. Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database Syst Rev. 2002:CD003692.

    Google Scholar 

  12. Khan NR, Tsivgoulis G, Lee SL, Jones GM, Green CS, Katsanos AH, et al. Fibrinolysis for intraventricular hemorrhage: an updated meta-analysis and systematic review of the literature. Stroke. 2014;45:2662–9.

    Article  PubMed  Google Scholar 

  13. Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled clear iii trial. Lancet. 2017;389(10069):603–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wang D, Liu J, Norton C, Liu M, Selim M. Local fibrinolytic therapy for intraventricular hemorrhage: a meta-analysis of randomized controlled trials. 6th World Intracranial Hemorrhage Conference, Baltimore, May 2017 (abstract).

    Google Scholar 

  15. Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden PL, Smith EE, et al. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76(14):1238–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.

    Article  CAS  PubMed  Google Scholar 

  17. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, et al. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke. 2010;41:48–53.

    Article  CAS  PubMed  Google Scholar 

  18. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358(20):2127–37.

    Article  CAS  PubMed  Google Scholar 

  19. Mayer SA, Davis SM, Skolnick BE, Brun NC, Begtrup K, Broderick JP, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke. 2009;40:833–40.

    Article  CAS  PubMed  Google Scholar 

  20. Gladstone D, Aviv R, Demchuk A, Hill MD, Thorpe K, Khoury J, Sucharew H, De Masi S, Ka L, Mamdani M, Al-Ajlan F, Carrozzella J, Jauch E, Broderick JP, Flaherty M; for the SPOTLIGHT and STOP-IT Study Steering Committee and Investigators. Randomized trial of hemostatic therapy for ‘Spot Sign’ positive intracerebral hemorrhage: primary results from the SPOTLIGHT/STOP-IT Collaboration. AHA International Stroke Conference, Houston, February 2017 (abstract).

    Google Scholar 

  21. Brown RD Jr, Wiebers DO, Torner JC, O’Fallon WM. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology. 1996;46(4):949–52.

    Article  PubMed  Google Scholar 

  22. Berman MF, Sciacca RR, Pile-Spellman J, Stapf C, Connolly ES Jr, Mohr JP, et al. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000;47(2):389–96; discussion 397.

    Article  CAS  PubMed  Google Scholar 

  23. ApSimon HT, Reef H, Phadke RV, Popovic EA. A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke. 33(12):2794–800.

    Google Scholar 

  24. Choi JH, Mohr JP. Brain arteriovenous malformations in adults. Lancet Neurol. 2005;4(5):299–308.

    Article  PubMed  Google Scholar 

  25. Brown RD Jr, Wiebers DO, Forbes G, O'Fallon WM, Piepgras DG, Marsh WR, et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg. 1998;68(3):352–7.

    Article  Google Scholar 

  26. Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350(9084):1065–8.

    Article  CAS  PubMed  Google Scholar 

  27. Wilkins RH. Natural history of intracranial vascular malformations: a review. Neurosurgery. 1985;16(3):421–30.

    Article  CAS  PubMed  Google Scholar 

  28. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990;73(3):387–91.

    Article  CAS  PubMed  Google Scholar 

  29. Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.

    Article  CAS  PubMed  Google Scholar 

  30. Hetts SW, Cooke DL, Nelson J, Gupta N, Fullerton H, Amans MR, et al. Influence of patient age on angioarchitecture of brain arteriovenous malformations. AJNR Am J Neuroradiol. 2014;35(7):1376–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614–21.

    Article  CAS  PubMed  Google Scholar 

  32. Hartmann A, Mast H, Mohr JP, Pile-Spellman J, Connolly ES, Sciacca RR, et al. Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke. 2005;36(11):2431–5.

    Article  PubMed  Google Scholar 

  33. Cunha e Sa MJ, Stein BM, Solomon RA, McCormick PC. The treatment of associated intracranial aneurysms and arteriovenous malformations. J Neurosurg. 1992;77(6):853–9.

    Article  PubMed  Google Scholar 

  34. Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurgery. 1994;34(1):2–6.

    PubMed  CAS  Google Scholar 

  35. Sure U, Butz N, Siegel AM, Mennel HD, Bien S, Bertalanffy H. Treatment-induced neoangiogenesis in cerebral arteriovenous malformations. Clin Neurol Neurosurg. 2001;103(1):29–32.

    Article  CAS  PubMed  Google Scholar 

  36. Ding D, Starke RM, Kano H, Mathieu D, Huang PP, Kondziolka D, et al. Stereotactic radiosurgery for ARUBA (a randomized trial of unruptured brain arteriovenous malformations)-eligible Spetzler-Martin grade I and II arteriovenous malformations: a multicenter study. World Neurosurg. 2017;102:507–17.

    Article  PubMed  Google Scholar 

  37. Morgan MK, Hermann Wiedmann MK, Stoodley MA, Heller GZ. Microsurgery for Spetzler-Ponce class A and B arteriovenous malformations utilizing an outcome score adopted from gamma knife radiosurgery: a prospective cohort study. J Neurosurg. 2016;23:1–12.

    Google Scholar 

  38. Ding D, Yen CP, Starke RM, Xu Z, Sun X, Sheehan JP. Radiosurgery for Spetzler-Martin grade III arteriovenous malformations. J Neurosurg. 2014;120(4):959–69.

    Article  PubMed  Google Scholar 

  39. Ding D, Yen CP, Xu Z, Starke RM, Sheehan JP. Radiosurgery for patients with unruptured intracranial arteriovenous malformations. J Neurosurg. 2013;118(5):958–66.

    Article  PubMed  Google Scholar 

  40. Maruyama K, Kawahara N, Shin M, Tago M, Kishimoto J, Kurita H, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352(2):146–53.

    Article  CAS  PubMed  Google Scholar 

  41. Chaudhary MY, Sachdev VP, Cho SH, Weitzner I Jr, Puljic S, Huang YP. Dural arteriovenous malformation of the major venous sinuses: an acquired lesion. AJNR Am J Neuroradiol. 1982;3(1):13–9.

    PubMed  CAS  Google Scholar 

  42. Watanabe A, Takahara Y, Ibuchi Y, Mizukami K. Two cases of dural arteriovenous malformation occurring after intracranial surgery. Neuroradiology. 1984;26(5):375–80.

    Article  CAS  PubMed  Google Scholar 

  43. Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology. 1995;194(3):671–80.

    Article  CAS  PubMed  Google Scholar 

  44. Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg. 1995;82(2):166–79. Erratum in: J Neurosurg. 1995 Apr;82(4):705–6.

    Article  CAS  PubMed  Google Scholar 

  45. Davies MA, TerBrugge K, Willinsky R, Coyne T, Saleh J, Wallace MC. The validity of classification for the clinical presentation of intracranial dural arteriovenous fistulas. J Neurosurg. 1996;85(5):830–7.

    Article  CAS  PubMed  Google Scholar 

  46. Davies MA, Saleh J, Ter Brugge K, Willinsky R, Wallace MC. The natural history and management of intracranial dural arteriovenous fistulae. Part 1: benig lesions. Interv Neuroradiol. 1997;3(4):295–302.

    Article  CAS  PubMed  Google Scholar 

  47. Davies MA, Ter Brugge K, Willinsky R, Wallace MC. The natural history and management of intracranial dural arteriovenous fistulae. Part 2: aggressive lesions. Interv Neuroradiol. 1997;3(4):303–11.

    Article  CAS  PubMed  Google Scholar 

  48. Duffau H, Lopes M, Janosevic V, Sichez JP, Faillot T, Capelle L, et al. Early rebleeding from intracranial dural arteriovenous fistulas: report of 20 cases and review of the literature. J Neurosurg. 1999;90(1):78–84.

    Article  CAS  PubMed  Google Scholar 

  49. Willinsky R, Terbrugge K, Montanera W, Mikulis D, Wallace MC. Venous congestion: an MR finding in dural arteriovenous malformations with cortical venous drainage. AJNR Am J Neuroradiol. 1994;15(8):1501–7.

    PubMed  CAS  Google Scholar 

  50. van Dijk JM, terBrugge KG, Willinsky RA, Wallace MC. Clinical course of cranial dural arteriovenous fistulas with long-term persistent cortical venous reflux. Stroke. 2002;33(5):1233–6.

    Article  PubMed  Google Scholar 

  51. van Dijk JM, TerBrugge KG, Willinsky RA, Wallace MC. Multiplicity of dural arteriovenous fistulas. J Neurosurg. 2002;96(1):76–8.

    Article  PubMed  Google Scholar 

  52. Roy D, Raymond J. The role of transvenous embolization in the treatment of intracranial dural arteriovenous fistulas. Neurosurgery. 1997;40(6):1133–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Authors would like to thank Dr. Reid Gooch from the Department of Neurosurgery, Thomas Jefferson University for sharing a case of brain arteriovenous malformation for presentation in this chapter.

Author information

Authors and Affiliations

  1. Departments of Neurology and Neurosurgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA

    Nabeel A. Herial

  2. Department of Neurology, Stroke Division, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Magdy Selim

Authors
  1. Nabeel A. Herial
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magdy Selim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nabeel A. Herial .

Editor information

Editors and Affiliations

  1. University of California, San Francisco Medical Center, San Francisco, CA, USA

    Bruce Ovbiagele

  2. University of Minnesota, Minneapolis, MN, USA

    Adnan I. Qureshi

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Herial, N.A., Selim, M. (2018). Special Disease Management Considerations. In: Ovbiagele, B., Qureshi, A. (eds) Intracerebral Hemorrhage Therapeutics. Springer, Cham. https://doi.org/10.1007/978-3-319-77063-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-77063-5_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-77062-8

  • Online ISBN: 978-3-319-77063-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation